← back to search

David Lyden

Cornell University · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Extracellular vesicles in disease, Cancer Cells and Metastasis, MicroRNA in disease regulation, and Immune cells in cancer.
h-index
75
citations
53,854
works
311
NIH funding
primary concept
Medicine
email

Recent publications

Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
Cell 2025cited by 44position: lastdoi
The Space Omics and Medical Atlas (SOMA) and international astronaut biobank
Nature 2024cited by 97position: middledoi
Molecular and physiological changes in the SpaceX Inspiration4 civilian crew
Nature 2024cited by 55position: middledoi
Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight
Nature Communications 2024cited by 54position: middledoi
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
Nature Medicine 2024cited by 52position: lastdoi
Collection of biospecimens from the inspiration4 mission establishes the standards for the space omics and medical atlas (SOMA)
Nature Communications 2024cited by 34position: middledoi
Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
Nature Cancer 2024cited by 25position: lastdoi
Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load
Cell Reports 2024cited by 22position: middledoi
Tumour extracellular vesicles and particles induce liver metabolic dysfunction
Nature 2023cited by 254position: lastdoi
Immune determinants of the pre-metastatic niche
Cancer Cell 2023cited by 189position: lastdoi
Genomic mapping of metastatic organotropism in lung adenocarcinoma
Cancer Cell 2023cited by 87position: middledoi
Tumor-derived nanoseeds condition the soil for metastatic organotropism
Seminars in Cancer Biology 2023cited by 47position: lastdoi
Breast adipose tissue‐derived extracellular vesicles from obese women alter tumor cell metabolism
EMBO Reports 2023cited by 23position: middledoi
Collection of Biospecimens from the Inspiration4 Mission Establishes the Standards for the Space Omics and Medical Atlas (SOMA)
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 4position: middledoi
Extracellular vesicles and particles impact the systemic landscape of cancer
The EMBO Journal 2022cited by 120position: lastdoi
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
Nature Communications 2022cited by 79position: middledoi
Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression
Nature Communications 2022cited by 64position: middledoi
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
Frontiers in Oncology 2022cited by 31position: middledoi
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
Nature Cancer 2021cited by 181position: middledoi
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain
Nature Cancer 2021cited by 130position: middledoi
Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
Cancer Research 2021cited by 112position: middledoi
Extracellular vesicle– and particle-mediated communication shapes innate and adaptive immune responses
The Journal of Experimental Medicine 2021cited by 80position: lastdoi
Calcium signaling induces a partial EMT
EMBO Reports 2021cited by 73position: middledoi
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings
Molecular Oncology 2021cited by 38position: middledoi
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
Cell stem cell 2020cited by 673position: middledoi
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma
JAMA Surgery 2020cited by 115position: middledoi
An exosome pathway without an ESCRT
Cell Research 2020cited by 85position: lastdoi
Cell-free DNA (cfDNA) and Exosome Profiling from a Year-Long Human Spaceflight Reveals Circulating Biomarkers
iScience 2020cited by 56position: middledoi
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
STAR Protocols 2020cited by 40position: lastdoi
Exosome-Mediated Metastasis: Communication from a Distance
Developmental Cell 2019cited by 1,318position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Irina Matei · Cornell University11 papers (2012–2024)Héctor Peinado · Centro Nacional de Epidemiología9 papers (2012–2017)Jacqueline Bromberg · Memorial Sloan Kettering Cancer Center9 papers (2012–2017)Haiying Zhang · Jilin University7 papers (2014–2022)Cyrus M. Ghajar · Fred Hutch Cancer Center5 papers (2012–2021)Laura Daly · University of California, Berkeley5 papers (2012–2017)Candia M. Kenific · Cornell University5 papers (2019–2023)Mina J. Bissell · University of California, Berkeley4 papers (2013–2021)Ayuko Hoshino · Tokyo Institute of Technology4 papers (2014–2020)Rosandra N. Kaplan · Center for Cancer Research4 papers (2012–2017)Bruno Costa‐Silva · Champalimaud Foundation3 papers (2012–2017)Fanny A. Pelissier Vatter · Swiss Institute for Regenerative Medicine3 papers (2020–2023) · 3 papers (2016–2017)Serena Lucotti · Cornell University3 papers (2020–2022)Pasquale Sansone · Children's Cancer and Blood Foundation3 papers (2016–2017)Basant Kumar Thakur · Essen University Hospital3 papers (2014–2017)Han Sang Kim · Sungkyunkwan University3 papers (2016–2022)Caitlin Williams · UNSW Sydney3 papers (2012–2015) · 3 papers (2016–2017)Yibin Kang · Rutgers, The State University of New Jersey2 papers (2012–2017)